JOHN PAUL D'ANTONIO

249 Pennington Rocky Hill Road * Hopewell Township, New Jersey, 08534 * Cell: 60
9-730-1919 * jd10adb34@westpost.net

EXECUTIVE PROFILE
LIFE SCIENCES SUBJECT MATTER SPECIALIST WITH UNIQUE COMBINATION OF DIRECT PHARMA
CEUTICAL INDUSTRY EXPERIENCE AND "BIG 5" CONSULTING
P&L executive accomplished at selling and delivering complex transformational so
lutions and cutting edge technologies across the pharmaceutical and life science
value chain. Seasoned performer with strong entrepreneurial skills, business ac
umen and technology savvy experienced in leading the design and implementation o
f business development and growth strategies. High-energy contributor and change
agent, consistently delivering powerful results aligning solutions with busines
s goals.

CORE LEADERSHIP COMPETENCIES

Client Origination, Development, Growth and Delivery * Portfolio Management * T
hought Leadership * New Solution or Product Development and Launch * Business De
velopment, Licensing and Acquisitions * Supply Chain and Off-shoring * Clinical
Development Process Improvement * R&D Pipeline Risk Assessment * IP Management *
Technology Management and Strategy * Board Level Presentations * Project/Progra
m Management * e-Business Strategy and Implementation
PROFESSIONAL EXPERIENCE
PHARMACEUTICAL AND LIFE SCIENCES ADVISORY SERVICES 2009- Present
SOLO PRACTICTIONER
Independent consulting and advisory services
Helping provide clients with thought leadership to navigate the shifting global
landscape centered on R&D risk assessment, strategic alliance management, and in
novation management
*Retained by Microsoft affiliate to develop and lead pursuit of $60 million clin
ical trial transformational engagement designed to reduce total cost of ownershi
p of information/software environment, improve data integrity and quality, enabl
e environment to flex with changes in business strategy and approach.
*Developed and executed program to use a form of AI software and applied decisio
n analytics to make "go-no-go" decisions to abandon or accelerate most promising
drug candidates in Phase I valued at $200mm+.
PRINCIPAL AND STRATEGY EXPERT, LIFE SCIENCES R&D 2008-2009
COMPUTER SCIENCES CORPORATION, INC.
Top ten global consulting, systems development and integration company
Lead strategy SME for life sciences R&D practice. Developed strategy and helped
launch 12 cutting edge solutions for licensing, clinical trials and risk mitigat
ion. Included sales and delivery against $5.5 mm budget.
*Designed strategy and tactics to transform CSC's Life Sciences sector into a Bi
oIT firm through strategic partnering and a $600MM CRO acquisition receiving boa
rd consideration and strategy approval.
*Created vision, strategy and business area architecture integrating critical bu
siness issues into the R&D process for world class biotech client to accommodate
explosive growth of $300 mm -$1.5 Bn in 12 mos.
DIRECTOR, PHARMACEUTICALS AND LIFE SCIENCES ADVISORY 2007- 2008
PRICEWATERHOUSECOOPERS, LLC.
Top five global advisory services firm for pharmaceutical and life sciences
Responsible for developing strategy and implementation of new service lines desi
gned to reduce economic risk in clinical trials and in-licensing shortening time
to submission. Included sales and delivery - $4.5 mm budget.
*Assessed CRO compliance to agreement with leading specialty pharma company unco
vering in excess of $10 mm in over payments for a milestone triggered by full pa
tient enrollment that was missed.
*Established off-shoring operating model and risk assessed CRO and CMO acquisiti
on candidates in India and China for ENDO and Proctor and Gamble Pharmaceuticals
.
*Provided industry perspective as SME for IP Asset Management practice for valua
tion of drug delivery systems, drug-device combinations and diagnostics technolo
gies for $100+ mm portfolio for Stryker.
MANAGINGPARTNER
1995-2007
PCI, INC., WASHINGTON'S CROSSING, NJ
Innovation Management and Technology Consulting, Pharmaceuticals and Biotechnolo
gyResponsible for strategy and tactics for technology funding and strategic alli
ances for emerging growth companies. Functioned in BD role guiding both small a
nd large companies seeking technology innovation.
In-licensing and Acquisitions Transaction Support
Pharmaceuticals
*Backed with $300 million in cash for early US expansion, originated and perform
ed initial due-diligence for multiple acquisition targets and meeting key criter
ia for purchase by STADA, a $1.2 Bn generic firm.
Drug Delivery Systems
*Originated, structured, negotiated and closed licensing, development and supply
transactions for six breakthrough drug delivery systems worth $234 million.
*In-licensed and launched first solid oral, rapid disintegration analgesic from
BioVail (Ethypharm) into the $1+ Bn OTC area with BioVail (Ethypharm) for Immuno
genetics, Inc.
Portfolio Strategy Development and Marketing Solutions
Pharmaceuticals
*Co-directed global strategic planning process for Ortho McNeil resulting in act
ionable, practical solutions for their diabetes, contraceptive, oncology, wound
care and anti-infective franchises, at Interpublic Group.
Drug Delivery Systems
*Propelled and ran US business development for Elan Pharma on behalf of its majo
rity stockholder, Sanders Morris Harris, a 10+ Bn investment firm, resulting in
multi-million dollar pharma alliances.
Turnarounds and Re-Engineering
Biotech
*Re-engineered core technology for a $40mm venture backed company after Phase II
/III failure - conceived and executed strategy resulting in an OTC switch genera
ting $5+ million in revenue year one.
Wound Care
*Turned around losing surgical products investment for the Avenir Group, a priva
tely equity firm, increasing sales to $14 mm from $12 and a net loss of 10% to
pre-tax profit 30% over the prior year.
PRIOR EMPLOYMENT
CAMBREX CORPORATION, Director, Sales, Marketing and Business Development
1992-1995
AMERICAN MEDICAL PRODUCTS, CORP., Chief Executive Officer
1988-1991
BRISTOL-MYERS SQUIBB, Manager Licensing and Acquisitions 1983-1986
EDUCATION
Lehigh University, Bethlehem, PA, BA Foreign languages - Proficient in Italia
n and Spanish
Activities: Squash, long distance runner